MERCK & CO: Mulls Options on Revoked Fosamax Patent in Europe

Subscribe
TOPICS: Biotechnology | Drugs/Pharmaceuticals | Legal Issues, Litigation | Patents, Intellectual Prop. | SEC-Qtrly, Annual Reports | Securities & Exch Comm, US
LOCATIONS: Europe | New Jersey | United States